These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34830241)

  • 1. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.
    Naorem LD; Prakash VS; Muthaiyan M; Venkatesan A
    Int J Biol Macromol; 2020 Feb; 145():429-436. PubMed ID: 31883894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
    Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S
    Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
    De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
    Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
    Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
    Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer.
    Li F; Zhou C; Li S; Wang J; Li M; Mu H
    Medicine (Baltimore); 2023 Jan; 102(3):e32573. PubMed ID: 36701720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
    Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
    Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
    Chen P; Zhang W; Chen Y; Zheng X; Yang D
    Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
    Hu D; Zhang B; Yu M; Shi W; Zhang L
    Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
    Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
    Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.